Do Trazodone or Memantine (Namenda) Decrease Serum Sodium?
Yes, trazodone can cause hyponatremia, while memantine does not typically decrease sodium levels.
Trazodone and Hyponatremia
Trazodone carries a documented risk of causing hyponatremia through SIADH (syndrome of inappropriate antidiuretic hormone secretion). The FDA drug label explicitly warns that hyponatremia may occur with trazodone treatment, with cases reported where serum sodium dropped below 110 mmol/L 1. This occurs because trazodone, as a serotonergic antidepressant, can trigger SIADH, leading to water retention and dilutional hyponatremia.
Key Risk Factors for Trazodone-Induced Hyponatremia:
- Elderly patients (highest risk group)
- Female gender
- Concurrent diuretic use
- Volume depletion
- Early treatment period (hyponatremia can develop rapidly) 1, 2
Clinical Presentation:
Signs range from mild (headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness leading to falls) to severe (hallucinations, syncope, seizures, coma, respiratory arrest, death) 1.
Management Approach:
- Monitor serum sodium early in treatment, particularly in the first weeks for high-risk patients
- If symptomatic hyponatremia develops, discontinue trazodone immediately and institute appropriate medical intervention 1
- The FDA label specifically identifies elderly patients, those on diuretics, and volume-depleted individuals as requiring heightened vigilance 1
Memantine (Namenda) and Sodium
Memantine does not cause hyponatremia. The FDA drug label for Namenda makes no mention of hyponatremia as an adverse effect 3. Memantine is predominantly renally eliminated and does not interfere with sodium homeostasis through hormonal mechanisms like SIADH.
Important Memantine Considerations:
- Renal dosing required: Dose reduction needed in severe renal impairment (CrCl 5-29 mL/min) 3
- Alkaline urine increases memantine levels: Conditions or drugs that alkalinize urine (carbonic anhydrase inhibitors, sodium bicarbonate) can reduce memantine clearance by ~80%, potentially increasing adverse effects—but not hyponatremia 3
- Drug interactions: Coadministration with other renally eliminated cationic drugs (hydrochlorothiazide, triamterene, metformin, cimetidine) may alter plasma levels of both agents, but this does not translate to sodium disturbances 3
Clinical Bottom Line
For trazodone: Check baseline sodium before initiating treatment in elderly patients, those on diuretics, or with volume depletion. Recheck sodium within 2-4 weeks of starting therapy or with any dose increase. Educate patients about symptoms of hyponatremia (confusion, weakness, falls, headache).
For memantine: No sodium monitoring required specifically for this medication. Focus monitoring on renal function and avoid drugs that alkalinize urine.
Common Pitfall to Avoid:
Do not assume all psychotropic medications carry equal hyponatremia risk. While SSRIs and SNRIs are well-known culprits 2, 4, trazodone—often prescribed as a "safer" sleep aid—carries significant hyponatremia risk that is frequently overlooked in clinical practice. Memantine, despite being used in the same patient populations (elderly with cognitive impairment), does not share this risk.